• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchAllon Therapeutics
    Picture of Allon Therapeutics logo

    NPCUF — Allon Therapeutics Share News

    $0.000.000.00%
    us flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro Cap
    • Market Cap
      $0.01m
    • Enterprise Value
      -$0.42m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • NPCUF Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    NPCUF Dividends
    • Brief: Aquestive Therapeutics Receives FDA Response To Citizen’S Petition

      12/01/2020 23:51
    • Brief: Aquestive Therapeutics Exceeds Top End Of Guidance Range For Preliminary Unaudited Full Year 2019 Total Revenues And Provides Initial Full Year 2020 Guidance

      10/01/2020 11:37
    • Brief: Aquestive Therapeutics Announces Pricing Of Public Offering Of Common Stock

      13/12/2019 01:08
    • Brief: Aquestive Therapeutics Announces Proposed Public Offering Of $35 Mln Shares Of Common Stock

      10/12/2019 21:44
    • Brief: Aquestive Therapeutics Reports Q3 Results And Raises 2019 Guidance

      05/11/2019 22:45

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.